Enrolling by invitation OBSERVATIONAL NCT07658547

Medical-AI trial: how do people with mental illness use AI chatbots for mental health? a survey of use, expectations, and concerns (NCT07658547)

Medizinische Hochschule Brandenburg Theodor Fontane Updated 2026-06-22

An online observational survey of how adults in psychiatric or psychotherapeutic treatment use, perceive, and evaluate generative-AI chatbots for mental-health purposes, asking about usage patterns, expectations, experiences, perceived benefits, barriers, and concerns. The primary outcome is the percentage who have used generative AI for mental-health issues. 150 participants.

Trial overview (primary data)

  • StatusEnrolling by invitation
  • ConditionsSevere Mental Illness
  • SponsorMedizinische Hochschule Brandenburg Theodor Fontane
  • Target enrollment150 participants
  • Period2026-06-01 〜 2026-11-01

Key points

  • An online observational survey of how adults in psychiatric or psychotherapeutic treatment use, perceive, and evaluate generative-AI chatbots for mental health.
  • It asks about usage patterns, expectations, experiences, perceived benefits, barriers, and concerns.
  • The primary outcome is the percentage who have used generative AI for mental-health issues. 150 participants, by invitation.
  • Its strength is capturing reality from those directly affected; the backdrop is convenience alongside safety, crisis-handling, and privacy concerns.
  • A survey describing use and perceptions; it does not evaluate or establish therapeutic effect or safety.

Generative-AI chatbots such as ChatGPT have quickly become a familiar partner for talking through worries and gathering information. In mental health too, some people use AI to voice concerns such as sleeplessness or anxiety. Alongside the convenience of an always-available listener, concerns are raised about wrong advice, crisis handling, and privacy.

So how do people actually in psychiatric treatment use AI chatbots, and how do they feel about them? This survey captures that from the voices of those directly affected.

Per the registry summary, this observational study surveys adults receiving psychiatric or psychotherapeutic treatment about how they use, perceive, and evaluate generative-AI chatbots for mental-health purposes.

It asks about usage patterns, expectations, experiences, perceived benefits, barriers, and concerns, with the main questions being how people with mental disorders use AI chatbots in the context of their mental health and what expectations, attitudes, and experiences they hold. The primary outcome is the percentage who have used generative AI for mental-health issues.

Participants provide electronic informed consent; the size is 150, conducted by invitation.

Mental-health use of AI chatbots is one of the most debated topics today, where the potential to widen access coexists with concerns about safety, dependence, and misinformation. Understanding, as fact, how those actually living with mental illness use AI and what they seek and fear, not only expert opinion, is a foundation for safe guidelines and support design.

That said, this study describes use and perceptions; it does not evaluate or establish the therapeutic effect or safety of AI chatbots.

Why it matters

Mental-health use of AI chatbots is a debated area where potential to widen access coexists with concerns about safety, dependence, and misinformation. Surveying the actual use and perceptions of those affected is a foundation for safe guidelines and support design (this study describes use, not therapeutic effect or safety).

FAQ

Is this a study that treats people with AI?
No. It is an observational survey of how people living with mental illness use and perceive generative-AI chatbots. It does not evaluate or establish the effect or safety of AI treatment.
Why is surveying patients important?
Because understanding the actual use, expectations, and concerns of those using AI, not only expert opinion, is a foundation for designing safe guidelines and support.

Sources (primary)

Source: ClinicalTrials.gov (U.S. NIH/NLM, public domain). This site does not provide medical advice. Verify the latest and exact details with the official source. This site is not endorsed or certified by the NIH/NLM.

#Medical AI#Clinical trial#Psychiatry#Mental health#Generative AI#Chatbot
Disclaimer: This site independently summarizes and classifies information based on official data sources. Always verify the latest and accurate information with the official sources. Content on finance, health, legal, and security is information, not advice. This site is not an official website of the U.S. government.